Read about Endologix
in the news

Embrace the evidence.

The Latest:

Endologix Announces 1000 patients treated with the DETOUR™ System.

See Release

All News

Archives

Endologix LLC Announces Enrollment of First Patients in ELEVATE IDE Clinical Study

In Memoriam of Dr. Ted Diethrich 1935-2017

Endologix Completes Patient Enrollment in the Ovation(R) LUCY Study First Prospective Study Evaluating EVAR in a Female Population

Endologix Announces Appointment of Dan Lemaitre as Chairman of the Board John McDermott to Continue as Chief Executive Officer

Positive Three-Year Results from the Ovation® European Post Market Registry Presented at 2017 LINC Symposium